Multiple endocrinopathies, hypercalcaemia and pancreatitis following combined immune checkpoint inhibitor use- case report and review of literature

BACKGROUND: Immune checkpoint inhibitors (ICIs) are a novel class of oncological agents which are used to treat a number of malignancies. To date seven agents have been approved by the Food and Drug Administration (FDA) to treat both solid and haematological malignancies. Despite their efficacy they...

Descripción completa

Detalles Bibliográficos
Autores principales: Newman, Christine, Kgosidalwa, Oratile, Hakami, Osamah A., Kennedy, Carmel, Grogan, Liam, Agha, Amar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912868/
https://www.ncbi.nlm.nih.gov/pubmed/33639911
http://dx.doi.org/10.1186/s12902-021-00693-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912868/
https://www.ncbi.nlm.nih.gov/pubmed/33639911
http://dx.doi.org/10.1186/s12902-021-00693-x

Ejemplares similares